DNTH logo

Dianthus Therapeutics (DNTH) Cash From Investing

Annual CFI

$20.25 M
+$80.07 M+133.86%

December 31, 2023


Summary


Performance

DNTH Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNTHcash flowmetrics:

Quarterly CFI

-$259.36 M
-$260.53 M-22286.83%

September 30, 2024


Summary


Performance

DNTH Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNTHcash flowmetrics:

TTM CFI

-$271.94 M
-$247.86 M-1029.31%

September 30, 2024


Summary


Performance

DNTH TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherDNTHcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

DNTH Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+133.9%-2154.4%-1054.5%
3 y3 years+10000.0%-2154.4%-1054.5%
5 y5 years+10000.0%-2154.4%-1054.5%

DNTH Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+133.9%-1286.3%at low-1054.5%at low
5 y5-yearat high+133.9%-1286.3%at low-1054.5%at low
alltimeall timeat high+133.9%-1286.3%at low-1054.5%at low

Dianthus Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$259.36 M(<-9900.0%)
-$271.94 M(+1029.3%)
Jun 2024
-
$1.17 M(-121.2%)
-$24.08 M(+611.4%)
Mar 2024
-
-$5.51 M(-33.1%)
-$3.38 M(-116.7%)
Dec 2023
$20.25 M
-$8.24 M(-28.4%)
$20.25 M(-28.9%)
Sep 2023
-
-$11.51 M(-152.6%)
$28.49 M(-498.0%)
DateAnnualQuarterlyTTM
Jun 2023
-
$21.86 M(+20.6%)
-$7.16 M(-75.3%)
Mar 2023
-
$18.13 M(-138.5%)
-$29.02 M(-38.5%)
Dec 2022
-$59.82 M(>+9900.0%)
-
-
Sep 2022
-
-$47.15 M
-$47.15 M
Dec 2021
-$33.00 K
-
-

FAQ

  • What is Dianthus Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Dianthus Therapeutics?
  • What is Dianthus Therapeutics annual CFI year-on-year change?
  • What is Dianthus Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Dianthus Therapeutics?
  • What is Dianthus Therapeutics quarterly CFI year-on-year change?
  • What is Dianthus Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Dianthus Therapeutics?
  • What is Dianthus Therapeutics TTM CFI year-on-year change?

What is Dianthus Therapeutics annual cash flow from investing activities?

The current annual CFI of DNTH is $20.25 M

What is the all time high annual CFI for Dianthus Therapeutics?

Dianthus Therapeutics all-time high annual cash flow from investing activities is $20.25 M

What is Dianthus Therapeutics annual CFI year-on-year change?

Over the past year, DNTH annual cash flow from investing activities has changed by +$80.07 M (+133.86%)

What is Dianthus Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of DNTH is -$259.36 M

What is the all time high quarterly CFI for Dianthus Therapeutics?

Dianthus Therapeutics all-time high quarterly cash flow from investing activities is $21.86 M

What is Dianthus Therapeutics quarterly CFI year-on-year change?

Over the past year, DNTH quarterly cash flow from investing activities has changed by -$247.86 M (-2154.36%)

What is Dianthus Therapeutics TTM cash flow from investing activities?

The current TTM CFI of DNTH is -$271.94 M

What is the all time high TTM CFI for Dianthus Therapeutics?

Dianthus Therapeutics all-time high TTM cash flow from investing activities is $28.49 M

What is Dianthus Therapeutics TTM CFI year-on-year change?

Over the past year, DNTH TTM cash flow from investing activities has changed by -$300.43 M (-1054.51%)